Written by Ad OpsOverview
Mota CBD Rich is a CBD-forward cannabis cultivar released by LaMota Seeds, a Spanish breeder known for producing European-market hybrids with targeted chemotypes. The strain is described by the breeder as an indica/sativa hybrid, positioning it as a balanced option for growers and consumers who want the calming influence of CBD without heavy intoxication. In practical terms, that usually means a chemotype geared toward moderate-to-high CBD content and low-to-moderate THC, delivering clear-headed effects and broad therapeutic potential.
While precise lab numbers for this specific line vary by phenotype and cultivation method, CBD-rich hybrids commonly reach 8–15% CBD with 0.3–8% THC, and Mota CBD Rich is typically selected to land within that performance envelope. Those ranges support versatile applications—functional daytime usage, reduction of THC’s psychoactivity, and more comfortable entry points for new consumers. For cultivators, the balanced indica/sativa morphology often translates to manageable plant height, cooperative internodal spacing, and reliable yields under indoor and outdoor programs.
The market for CBD-select cultivars has grown steadily since 2017, and CBD products accounted for an estimated multi-billion-dollar global market by 2024. A strain like Mota CBD Rich competes by emphasizing cannabinoid consistency, approachable terpenes, and user-friendly cultivation. In European homegrow circles, such CBD-dominant seeds are valued for delivering medicinally useful flowers while minimizing risk of over-intoxication or anxiety associated with high-THC varieties.
History
LaMota Seeds emerged from Spain’s dynamic cannabis scene, where breeders and retailers helped popularize feminized and CBD-leaning lines across the EU. As regulations evolved and consumer demand for wellness-oriented cannabis increased, breeders prioritized lines that maintained resin quality while dialing back THC. Mota CBD Rich fits squarely in that progression, offering a cultivar built for modern users who want reliable CBD outcomes from a photoperiod hybrid.
The CBD-rich category matured in the late 2010s with high-profile releases and clinical data that framed CBD as non-intoxicating and generally well-tolerated. By 2020–2024, CBD cultivars with THC under 1–8% became increasingly common in both homegrow and hemp-adjacent markets. Mota CBD Rich reflects that maturation, aiming for repeatable cannabinoid ratios rather than chasing extreme potency.
According to genealogy pages that aggregate breeder information, Mota CBD Rich appears in networks tied to notable hybrid families. Seed genealogies often catalog “mothers,” backcrosses, and related crosses, and in this case they show connections relevant to Original Strains’ entries and other modern hybrids. This context is typical of CBD-forward work, where breeders blend stabilized chemotypes with robust hybrid vigor to achieve consistent cannabinoid outcomes.
Genetic Lineage
The direct, publicly declared parentage of Mota CBD Rich has not been comprehensively disclosed by LaMota Seeds. However, third-party genealogy resources list the cultivar within family trees that include Original Strains’ “Unknown Strain” and also show connections to Goku Ssj4 (Grow Today Genetics) in extended lineages. Specifically, entries such as Original Strains’ Unknown Strain and Goku Ssj4 appear in the broader network of related hybrids and crosses, suggesting a modern, polyhybrid background common to CBD-focused selections.
It is important to note that these listings do not necessarily mean those two are the immediate parents of Mota CBD Rich. Rather, they indicate that Mota CBD Rich sits in a family of hybrids where these lines are present in the genealogy or are used in kin cultivars. In the CBD seed world, such genealogical mapping helps situate a strain’s chemotype tendencies—here, a balanced indica/sativa with a CBD-forward profile—without claiming a specific, breeder-verified cross.
From a phenotype perspective, growers usually observe hybrid vigor, moderate stretch in early bloom, and compact, resinous floral clusters. Those traits fit a selection strategy designed to combine manageable structure with a terpene profile that is pleasant but not overwhelming. The likely result is a cultivar that can be trained for indoor yields while holding up outdoors with moderate resistance to common pathogens.
Appearance
Mota CBD Rich typically grows with a hybrid architecture featuring a medium stature and strong lateral branching. Internodal spacing is moderate, helping light penetrate the canopy and minimizing larf when training is used. Fan leaves often exhibit broad leaflets in vegetative growth with slightly narrower expressions after the flip, reflecting its balanced indica/sativa heritage.
During flowering, buds present as tight, calyx-forward colas with visible pistil clusters that shift from creamy white to orange and amber hues as maturity approaches. Trichome coverage is generous, with capitate-stalked glands forming a frosty coat that is characteristic of well-selected CBD cultivars. The resin looks glassy under magnification, and trichome heads tend to amber slightly slower than some THC-dominant strains, which can extend the optimal harvest window by a few days.
Growers frequently report that Mota CBD Rich responds well to canopy training, producing uniform, satisfyingly dense tops. In ideal conditions, bracts swell substantially in the final two to three weeks of flower. The resulting bag appeal is elevated by the contrast between glistening trichomes and darker sugar leaves, especially after a careful dry and slow cure.
Aroma
The aromatic signature of Mota CBD Rich leans toward clean, herbal, and gently sweet notes rather than pungent fuel or skunk. Early in flower, the bouquet often shows fresh-cut herbs, citrus peel, and faint pine, which intensify as resin production peaks. When the flowers are cured, a subtle spice and wood undertone may emerge, rounding out the profile without becoming overpowering.
CBD-rich hybrids commonly carry myrcene- and caryophyllene-forward terpene balances, and Mota CBD Rich follows that pattern. The myrcene contributes the herbal, slightly earthy base, while beta-caryophyllene adds a peppery warmth on the back end. Secondary terpenes like limonene and pinene lend brightness, resulting in an overall nose that feels calming and approachable.
Proper curing enhances the aromatic layers, with 62% relative humidity packs helping preserve volatile terpenes. Stored in glass away from light and heat, the nose remains stable for several months, though a gradual decline in terpene intensity is expected. Consumers often describe the aroma as refreshing and clean, suitable for daytime sessions and discreet use.
Flavor
On the palate, Mota CBD Rich tends toward herbal-citrus flavors with a soft, woody finish. The inhale is usually smooth and lightly sweet, hinting at citrus zest and gentle pine. On the exhale, a mild pepper note surfaces, attributable to beta-caryophyllene, complemented by a faint floral nuance when the cure is extended.
Vaporization highlights the terpene layering more clearly than combustion, revealing brighter limonene and pinene top notes at lower temperatures. Many users prefer vaping in the 170–190°C range to preserve these monoterpenes and reduce harshness. Combustion presents a fuller, warmer flavor with a slightly more pronounced spice, which some consumers favor for depth.
Flavor stability tracks closely with curing protocol and storage conditions. A 10–14 day slow dry at around 60°F (15–16°C) and 58–62% RH, followed by a 4–8 week cure, tends to lock in sweetness and reduce chlorophyll harshness. Over-drying below 55% RH can flatten flavors and accelerate terpene loss, reducing the nuanced herbal-citrus character.
Cannabinoid Profile
CBD-forward hybrids like Mota CBD Rich are typically selected to achieve CBD in the 8–15% range with THC often below 8%, and sometimes as low as 0.3–1% in hemp-adjacent phenotypes. While precise lab results vary by grower and phenotype, the breeder’s intent is a dependable CBD-dominant chemotype that keeps intoxication subdued. In practice, balanced indica/sativa CBD cultivars often produce THC:CBD ratios around 1:10, 1:5, or 1:2, depending on selection and environmental factors.
The entourage effect describes how cannabinoids and terpenes interact to modulate pharmacology. Notably, CBD can attenuate some of THC’s psychoactive effects by acting as a negative allosteric modulator at CB1 receptors, and by influencing serotonin and TRP channels. Users commonly report clearer cognition and reduced anxiety with CBD-rich cultivars even when small amounts of THC are present.
Decarboxylation efficiency and route of administration influence effect intensity. Smoking or vaping typically decarboxylates most THCA/CBDA, while oral routes deliver lower peak plasma levels but longer duration; oral CBD bioavailability is often reported around 6–19%. For most users, 5–20 mg inhaled CBD-equivalent offers mild to moderate relief, while oral doses of 25–100 mg CBD are common in wellness contexts, with clinical dosing sometimes far higher under medical supervision.
Minor cannabinoids may appear in trace amounts. CBC and CBG are occasionally detected between 0.1–1% in CBD-first hybrids, adding anti-inflammatory and neuroactive potential to the chemotype. However, their presence and levels are highly environment- and phenotype-dependent, and consistent quantification requires third-party lab testing of each harvest.
Terpene Profile
Although terpene totals vary, CBD-dominant cultivars commonly test between 0.8–2.5% total terpenes by weight when grown and cured well. Mota CBD Rich often expresses myrcene, beta-caryophyllene, and limonene as primary contributors, with pinene, humulene, and linalool frequently present as secondaries. This balance supports a calm, fresh, and lightly spicy aromatic experience that matches its clear-headed effect profile.
Myrcene, often the most abundant terpene in hybrid cannabis, contributes herbal and earthy tones and may synergize with CBD’s relaxing feel. Beta-caryophyllene, a CB2 receptor agonist, imparts peppery spice and may support anti-inflammatory signaling without CB1 intoxication. Limonene supplies citrus brightness and is associated in research with mood-elevating properties, which users anecdotally perceive as uplift and focus.
Pinene and humulene add complexity with pine resin and dry hop notes, respectively, while linalool can introduce a gentle floral thread and soothing character. In cured flower, the top three terpenes often account for 60–80% of the total terpene content, shaping the dominant nose and flavor. Managing dry/cure conditions is crucial because monoterpenes like limonene and pinene volatilize rapidly in warm, arid environments.
For extraction, terpene retention is highest with low-temperature solventless rosin or hydrocarbon runs followed by careful post-processing. Flower destined for concentrate production benefits from harvest timing that preserves monoterpenes—usually slightly earlier than for maximum cannabinoid maturation. Even then, expect 10–30% losses in the most volatile fractions if handling is not meticulous.
Experiential Effects
Mota CBD Rich generally delivers a calm, non-sedating baseline that builds gradually over the first 5–10 minutes when inhaled. Users describe gentle body ease, a quieting of mental chatter, and maintained functional clarity. The experience is typically steady-state rather than spiky, with minimal short-term memory disruption compared to THC-dominant strains.
At higher doses or late in the day, the strain can feel mildly sedative, especially in phenotypes with higher myrcene and linalool. Most people report low anxiety potential, with CBD damping the jitteriness that some encounter with THC-forward cultivars. For focus-oriented activities, microdosing one or two small inhalations often suffices to obtain relaxation without lethargy.
Side effects are generally mild and align with cannabis norms: dry mouth, dry eyes, and occasional lightheadedness, particularly in new users. Because CBD can interfere with hepatic enzymes, some individuals might feel stronger or weaker effects from co-administered medications; caution and medical guidance are recommended. For oral use, onset takes 30–90 minutes, with effects that may last 4–8 hours depending on dose and metabolism.
Potential Medical Uses
CBD’s therapeutic profile has been explored in numerous clinical and preclinical studies, and CBD-rich flower like Mota CBD Rich can be a practical delivery format. In refractory epilepsy syndromes such as Dravet and Lennox–Gastaut, pharmaceutical-grade CBD has produced median seizure reductions of roughly 37–44% in pivotal trials. While whole-flower inhalation is not equivalent to standardized oral solutions, these data highlight CBD’s anticonvulsant potential and the rationale for CBD-forward cannabis in neurological contexts.
Anxiety is another domain where CBD shows promise. In simulated public speaking tests, acute oral CBD doses around 300–600 mg have reduced anxiety scores compared to placebo, with a bell-shaped dose-response. In real-world use, many patients report benefits at lower routine doses (e.g., 25–100 mg/day orally) or with small inhaled amounts that allow rapid titration before stressful tasks.
Chronic pain and inflammation may respond to CBD’s multimodal actions, including TRPV1 desensitization and CB2-associated pathways. Observational data indicate that CBD-rich cannabis can reduce opioid use in some chronic pain populations, though controlled trials are mixed and formulation-dependent. When THC is present in modest amounts—as it is in many CBD-rich flowers—some users experience synergistic analgesia with less intoxication than high-THC alternatives.
Sleep quality can improve indirectly when pain and anxiety are reduced. While CBD is not a classic hypnotic, many users of CBD-forward strains report easier sleep onset and fewer nighttime awakenings, especially when dosed in the evening. Phenotypes with more myrcene and linalool may accentuate this effect through their relaxing aromatics.
Safety considerations include potential drug–drug interactions via CYP3A4 and CYP2C19, particularly with anticoagulants, anticonvulsants, and certain antidepressants. Reported adverse effects of CBD at high doses include fatigue, diarrhea, and appetite changes, though these are uncommon at typical inhaled or low oral doses. As always, individuals with medical conditions should consult a clinician, especially when combining CBD with prescription medications.
Cultivation Guide
Mota CBD Rich performs reliably in both indoor and outdoor environments, reflecting its balanced indica/sativa heritage. Indoor growers can expect medium-height plants that respond predictably to topping, low-stress training (LST), and screen-of-green (ScrOG) techniques. Outdoors, the structure supports multiple well-lit tops, and the cultivar generally finishes by late September to early October in temperate latitudes, depending on phenotype.
Vegetative growth thrives at 24–28°C with 60–70% relative humidity and a VPD of roughly 0.8–1.1 kPa. Provide a PPFD of 350–600 µmol/m²/s under efficient LED fixtures with a DLI target of 20–30 mol/m²/day. In soil, maintain pH at 6.2–6.8; in coco, 5.8–6.2; and in hydroponics, 5.7–6.0. EC in early veg can be 1.2–1.6 mS/cm, rising to 1.6–1.8 mS/cm by late veg as plants ramp up growth.
During flowering, aim for daytime temperatures of 24–26°C and nighttime of 18–21°C. Drop humidity to 50–55% in early bloom and 45–50% in late bloom to discourage botrytis in the dense clusters common to CBD hybrids. Target PPFD around 700–900 µmol/m²/s at canopy for ambient CO₂ conditions; if supplementing CO₂ to 1000–1200 ppm, you can push 900–1100 µmol/m²/s provided irrigation and nutrition are dialed. Keep VPD between 1.2–1.6 kPa in mid-to-late flower.
Nitrogen demand is moderate; oversupply can prolong veggy growth and reduce terpene intensity. Use a balanced NPK feed in early bloom (e.g., N-P-K around 1-2-2) and transition to a bloom-focused ratio (e.g., 1-3-3 or 0-3-3) as pistil formation accelerates. Calcium and magnesium are critical—especially under LED lighting—so supplement with 100–150 ppm Ca and 50–75 ppm Mg during peak uptake. Watch potassium in late flower to support bulking; too much can antagonize calcium and magnesium uptake.
Flowering time is typically 8–9 weeks from the flip, though some phenotypes benefit from 63–70 days for optimal cannabinoid and terpene expression. For CBD-rich cultivars, harvest timing slightly earlier than for THC-maximization can preserve brighter monoterpenes and maintain a lower THC:CBD ratio. Monitor trichomes: a mostly cloudy field with only 5–10% amber is often ideal for a crisp, clear effect. Letting trichomes drift toward 20% amber can deepen relaxation at the expense of some citrus-forward brightness.
Yield potential is solid for a CBD-driven hybrid. In competent indoor setups, growers commonly achieve 400–550 g/m², with experienced cultivators and high-efficiency lighting reaching the upper end of that range. Outdoors in fertile soil with full sun, expect 500–1000 g per plant depending on veg time and training. Excessive nitrogen, insufficient light intensity, or poor canopy management are the usual reasons yields lag.
Pest and disease management follows best practices. Employ integrated pest management (IPM) with weekly scouting, yellow sticky traps, and prophylactic biological controls such as Bacillus subtilis or B. amyloliquefaciens for leaf pathogens, and predatory mites (e.g., Neoseiulus californicus) for spider mites. Maintain adequate airflow with 0.3–0.6 m/s canopy-level airspeed and prune interior larf to increase light penetration and reduce humidity pockets. Sanitation and environmental control prevent most issues before they start.
Irrigation should maintain moderate moisture with brief drybacks to encourage root oxygenation. In coco, irrigate to 10–20% runoff once to several times daily depending on pot size and plant stage; in soil, allow the top 2–3 cm to dry between waterings. Root-zone temperatures around 20–22°C support nutrient uptake; colder media can stall growth and promote calcium issues. Avoid pH drift by calibrating meters regularly and mixing nutrients in a consistent order.
Training techniques are straightforward and effective. Top once or twice in early veg, then LST branches to a flat, even canopy that fills your footprint. For ScrOG, flip when the net is 70–80% full to account for 25–60% stretch, which this hybrid often exhibits in the first two weeks of bloom. Defoliate lightly at day 21 and, optionally, day 42 of flower to clear shaded sites and improve airflow, but avoid aggressive stripping that can reduce photosynthetic capacity.
Post-harvest handling has an outsize influence on the final experience. Dry for 10–14 days at 15–18°C and 58–62% RH with gentle air exchange but no direct airflow on flowers. Cure in airtight glass with 62% humidity control packs, burping daily in the first week, then weekly for 4–8 weeks. Well-cured CBD-rich flower retains 0.8–2.5% total terpenes more reliably and delivers a smoother, fuller flavor profile.
If making extracts, select material harvested on the early side of peak maturity to capture monoterpenes, and freeze immediately if producing live products. For solventless hash or rosin, phenotypes with large, brittle trichome heads respond best; a 160–90 µm wash range often yields clean resin. Press at 85–95°C for 60–120 seconds to balance flavor and stability; higher temps or longer presses will darken the rosin and vent more volatiles.
Notes on Lineage Sources and Context
Public genealogy indexes, including Original Strains’ Unknown Strain Lineage & Hybrids, list Mota CBD Rich (LaMota Seeds) in proximity to entries like “Unknown Strain (Original Strains)” and show connections to Goku Ssj4 (Grow Today Genetics) within related hybrid networks. These listings help contextualize the cultivar within modern polyhybrid CBD breeding but do not necessarily constitute breeder-confirmed immediate parentage. LaMota Seeds officially characterizes Mota CBD Rich as an indica/sativa hybrid, consistent with the morphology and effect profile observed by growers.
Because CBD-rich breeding often involves multi-generational selections, backcrosses, and chemotype stabilization, public trees may compress complex histories into simple nodes. The takeaway for cultivators and consumers is the expected performance envelope: balanced growth, approachable aroma, and CBD-forward effects. For definitive parentage, consult the breeder’s latest releases or lab-backed phenohunt reports, and always verify with up-to-date seedbank documentation.
